Clinical trial

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney…

NCT00062621 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00062621
Title Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
Official title Combined HLA-matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With Renal Failure
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Immune Tolerance Network (ITN)
Status Completed
Phase Phase 1
Study type Interventional
Conditions Kidney Failure, Chronic, Multiple Myeloma
Intervention type Procedure
Interventions Combined bone marrow and kidney transplant
Enrollment 5
Start date Jun 1, 2003
Primary completion Dec 1, 2006
Completion Dec 1, 2006
First posted Jun 12, 2003
Last update posted Feb 5, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies